Get Started
COVID-19 Vaccines

According to a mathematical modelling analysis, the COVID-19 vaccine avoided about 20 million fatalities worldwide in the first year

Scancell's Clinical Trial

Scancell, a cancer and infectious disease treatment company, has announced that the first patient in its multicentre Modi-1 clinical trial (ModiFY)

COVID-19 Vaccine

The companies' shared goal was to help vulnerable areas by giving out immunizations.

COPD flare-ups

According to research conducted by the University of California San Francisco and funded by the US National Institutes of Health

Milestone Inhibitor

Jazz and Redx have reached an agreement on a milestone inhibitor

Treatment of Alzheimer's disease

A discovery in understanding Alzheimer's disease has revealed changes to blood vessels in the brain

Development of new drugs

SMC, a pharmaceutical and medical device company, has announced the launch of Cambridge Pharma

Presence of pharmaceuticals

According to the study, the Blue River in Tunis has one of the highest pharmaceutical concentrations.

Diabetic Medication

Mounjaro is a once-weekly glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that comes in a single molecule.

19th Clinical Trials Innovation

The forthcoming 19th Clinical Trials Innovation Program is a promising conference brought to you by World BI.

17th Drug Discovery Innovation

The upcoming 17th Drug Discovery Innovation Programme is a promising conference held by World BI

Administration of the pharmaceutical wholesalers

The Doncaster Pharmaceuticals Group has 14 locations across the United Kingdom.

Indian pharmaceutical company

India-based Piramal Pharma Solutions plans to create up to 50 new jobs by making antibody drugs under contract

Pharma Supply Chain

This year's Pharma Supply Chain and Logistics Innovation programme, held in the Courtyard Marriott by Basel, Switzerland

Augmented Reality

Augmented Reality (AR) Integrated into the Pharma Manufacturing and the Supply Chain

FDA Approved Lilly's Mounjaro

Mounjaro is a once-weekly glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1)